Antonio
Gómez Caamaño
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (12)
2022
-
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group
Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 446-459
2017
-
Radiation therapy in extensive stage small cell lung cancer
Frontiers in Oncology, Vol. 7, Núm. AUG
2016
-
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]
Reports of Practical Oncology and Radiotherapy
-
Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Clinical and Translational Oncology, Vol. 18, Núm. 4, pp. 331-341
-
GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases
Annals of Oncology, Vol. 27, pp. vi383
-
No role for trimodality therapy and consolidation chemotherapy compared with concurrent radiochemotherapy alone in stage III non-small-cell lung cancer
Journal of Clinical Oncology
2015
-
Imaging of Tumor Angiogenesis for Radiologists-Part 1: Biological and Technical Basis
Current Problems in Diagnostic Radiology, Vol. 44, Núm. 5, pp. 407-424
-
Imaging of Tumor Angiogenesis for Radiologists-Part 2: Clinical Utility
Current Problems in Diagnostic Radiology, Vol. 44, Núm. 5, pp. 425-436
-
The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy
Journal of Urology, Vol. 193, Núm. 6, pp. 1963-1969
-
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance
Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272
2013
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572
2010
-
Spanish radiobiological pattern of care in lung cancer: A GOECP/SEOR study
Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 292-298